In this EDGE - Beyond The Stage 1:1, Dr Tiffany Vora unpacks what “Is 150 the next 80?” really means - not just living longer, but extending healthspan. She shares the biotech breakthroughs making this plausible, from CRISPR gene editing to AI-enabled biology, and explains how leaders should rethink performance culture, succession planning, and multigenerational teams in a world of longer careers. She also flags the ethical risk of widening inequality if longevity tools remain accessible only to those with money.

Takeaways:
• “Healthspan” matters more than lifespan - the goal is longer, healthier productive lives.
• Biotech breakthroughs like “CRISPR” plus AI can accelerate medical advances in the next decade.
• Leaders should prepare now for longer careers and the inequality risks of unequal access to longevity tools.